A new £10 million investment will fund AI-powered robotic labs in Liverpool to accelerate breakthroughs in treatments for deadly infectious diseases.
A Leap for Life Sciences
- Located at the Liverpool School of Tropical Medicine (LSTM), the Containment Level 3 labs will use AI, robotics, and liquid handling systems to advance vaccine, drug, and diagnostic development.
- Backed by the Infection Innovation Consortium (iiCON), the labs aim to fast-track preclinical development and bolster collaboration between industry, NHS, and academia.
- This initiative is part of a £20M health innovation drive, expected to generate £40M in investment and create high-skill jobs within three years.
The project is a cornerstone of the Liverpool City Region’s Life Sciences Innovation Zone, projected to bring in £800M investment and 8,000 new jobs over a decade.
Follow MEDWIRE.AI for infection innovation updates.
